8-Jun-2026
Notable healthcare headlines for the week: UnitedHealth, Medtronic, and Eli Lilly in focus
Seeking Alpha News (Sun, 7-Jun 9:05 AM ET)
Agilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific Innovation
Business Wire (Wed, 3-Jun 7:00 AM ET)
Business Wire (Tue, 2-Jun 4:15 PM ET)
Agilent Raises Full-Year Outlook After Robust Q2 Performance and Margin Expansion
Market Chameleon (Thu, 28-May 7:53 AM ET)
Agilent’s New OpenLab Sync Sets a Digital Standard for Lab Efficiency and Compliance
Market Chameleon (Thu, 28-May 4:16 AM ET)
Agilent Introduces OpenLab Sync to Support Guided, Digital Execution in the Laboratory
Business Wire (Thu, 28-May 8:00 AM ET)
Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
Business Wire (Wed, 27-May 4:05 PM ET)
Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality Control
Business Wire (Tue, 26-May 8:00 AM ET)
Agilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data Quality
Business Wire (Tue, 26-May 8:00 AM ET)
Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis
Business Wire (Fri, 22-May 8:00 AM ET)
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Agilent Technologies trades on the NYSE stock market under the symbol A.
As of June 8, 2026, A stock price declined to $132.69 with 1,421,219 million shares trading.
A has a beta of 1.19, meaning it tends to be more sensitive to market movements. A has a correlation of 0.19 to the broad based SPY ETF.
A has a market cap of $37.45 billion. This is considered a Large Cap stock.
Last quarter Agilent Technologies reported $2 billion in Revenue and $1.49 earnings per share. This beat revenue expectation by $36 million and exceeded earnings estimates by $.08.
In the last 3 years, A traded as high as $160.27 and as low as $96.43.
The top ETF exchange traded funds that A belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
A has underperformed the market in the last year with a return of +17.3%, while SPY returned +25.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in A shares. However, A has outperformed the market in the last 3 month and 2 week periods, returning +12.6% and +15.4%, while SPY returned +8.8% and -0.9%, respectively. This indicates A has been having a stronger performance recently.
A support price is $132.49 and resistance is $138.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that A shares will trade within this expected range on the day.